Boulding Mark Elliott's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Feb 11, 2022
- Accession no.
- 0001179110-22-001094
- Filed
- Feb 11, 2022
- Trade date
- Feb 10, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $807.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boulding Mark ElliottCIK 0001578852 | Officer (Exec. VP and CLO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | MOption exerciseAcquired | +2,282 | $11.23 | +$25,626.86 | 63,392 | Direct | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −2,282 | $45.03F2 | −$102,758.46 | 61,110 | Direct | |
| Feb 10, 2022 | Common Stock | MOption exerciseAcquired | +15,653 | $18.01 | +$281,910.53 | 76,763 | Direct | |
| Feb 10, 2022 | Common Stock | SSaleDisposed | −15,653 | $45.03F2 | −$704,854.59 | 61,110 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2022 | Common Stock | MOption exerciseDisposed | −2,282 | $11.23 | −$25,626.86 | 2,281 | Direct | |
| Feb 10, 2022 | Common Stock | MOption exerciseDisposed | −15,653 | $18.01 | −$281,910.53 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $45.01 to $45.04 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 2 transactions in Table I.